196 related articles for article (PubMed ID: 29515258)
21. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.
Lu BY; Thanawala SU; Zochowski KC; Burke MJ; Carroll WL; Bhatla T
Leuk Lymphoma; 2016 Aug; 57(8):1938-41. PubMed ID: 26726842
[No Abstract] [Full Text] [Related]
22. The roles of aldo-keto reductases in steroid hormone action.
Bauman DR; Steckelbroeck S; Penning TM
Drug News Perspect; 2004 Nov; 17(9):563-78. PubMed ID: 15645014
[TBL] [Abstract][Full Text] [Related]
23. AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects.
Davies NJ; Hayden RE; Simpson PJ; Birtwistle J; Mayer K; Ride JP; Bunce CM
Cancer Res; 2009 Jun; 69(11):4769-75. PubMed ID: 19487289
[TBL] [Abstract][Full Text] [Related]
24. AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
Badmann S; Mayr D; Schmoeckel E; Hester A; Buschmann C; Beyer S; Kolben T; Kraus F; Chelariu-Raicu A; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Sci Rep; 2022 Feb; 12(1):1862. PubMed ID: 35115586
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives.
Sinreih M; Jójárt R; Kele Z; Büdefeld T; Paragi G; Mernyák E; Rižner TL
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1500-1508. PubMed ID: 34227437
[TBL] [Abstract][Full Text] [Related]
26. The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.
Li W; Hou G; Zhou D; Lou X; Xu Y; Liu S; Zhao X
Oncotarget; 2016 Apr; 7(16):21542-55. PubMed ID: 26934124
[TBL] [Abstract][Full Text] [Related]
27. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
Burczynski ME; Lin HK; Penning TM
Cancer Res; 1999 Feb; 59(3):607-14. PubMed ID: 9973208
[TBL] [Abstract][Full Text] [Related]
28. OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.
Evans K; Duan J; Pritchard T; Jones CD; McDermott L; Gu Z; Toscan CE; El-Zein N; Mayoh C; Erickson SW; Guo Y; Meng F; Jung D; Rathi KS; Roberts KG; Mullighan CG; Shia CS; Pearce T; Teicher BA; Smith MA; Lock RB
Clin Cancer Res; 2019 Jul; 25(14):4493-4503. PubMed ID: 31015346
[TBL] [Abstract][Full Text] [Related]
29. Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death.
Phoo NLL; Dejkriengkraikul P; Khaw-On P; Yodkeeree S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830394
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
Roderick JE; Gallagher KM; Murphy LC; O'Connor KW; Tang K; Zhang B; Brehm MA; Greiner DL; Yu J; Zhu LJ; Green MR; Kelliher MA
Blood; 2021 Jan; 137(4):500-512. PubMed ID: 33507291
[TBL] [Abstract][Full Text] [Related]
31. Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily.
Ruiz FX; Porté S; Gallego O; Moro A; Ardèvol A; Del Río-Espínola A; Rovira C; Farrés J; Parés X
Biochem J; 2011 Dec; 440(3):335-44. PubMed ID: 21851338
[TBL] [Abstract][Full Text] [Related]
32. Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate.
Khanim F; Davies N; Veliça P; Hayden R; Ride J; Pararasa C; Chong MG; Gunther U; Veerapen N; Winn P; Farmer R; Trivier E; Rigoreau L; Drayson M; Bunce C
Br J Cancer; 2014 Mar; 110(6):1506-16. PubMed ID: 24569460
[TBL] [Abstract][Full Text] [Related]
33. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
34. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: role in the cell cycle and apoptosis.
Selga E; Noé V; Ciudad CJ
Biochem Pharmacol; 2008 Jan; 75(2):414-26. PubMed ID: 17945194
[TBL] [Abstract][Full Text] [Related]
36. Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.
Murray JR; Mesaros CA; Arlt VM; Seidel A; Blair IA; Penning TM
Chem Res Toxicol; 2018 Nov; 31(11):1277-1288. PubMed ID: 30406992
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.
Shen Y; Liu Q; Lou S; Luo Y; Sun H; Zeng H; Deng J
Oncol Rep; 2017 Nov; 38(5):3130-3136. PubMed ID: 29048676
[TBL] [Abstract][Full Text] [Related]
38. Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile.
Novotná E; Büküm N; Hofman J; Flaxová M; Kouklíková E; Louvarová D; Wsól V
Arch Toxicol; 2018 Sep; 92(9):2845-2857. PubMed ID: 29992508
[TBL] [Abstract][Full Text] [Related]
39. Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
Peirs S; Frismantas V; Matthijssens F; Van Loocke W; Pieters T; Vandamme N; Lintermans B; Dobay MP; Berx G; Poppe B; Goossens S; Bornhauser BC; Bourquin JP; Van Vlierberghe P
Leukemia; 2017 Oct; 31(10):2037-2047. PubMed ID: 28074072
[TBL] [Abstract][Full Text] [Related]
40. PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.
Silveira AB; Laranjeira AB; Rodrigues GO; Leal PC; Cardoso BA; Barata JT; Yunes RA; Zanchin NI; Brandalise SR; Yunes JA
Oncotarget; 2015 May; 6(15):13105-18. PubMed ID: 25869207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
